Skip to content

UQUIFA SHARES THEIR INSIGHTS ON OLEFIN METATHESIS

  • September 9, 2019

With over 80 years of experience, UQUIFA’s business model is based on a combination of a quality manufacturing platform and a track record of service and reliability. They have four manufacturing sites (two in Spain, one in Hungary and one in Mexico) with strict adherence to all regulatory norms. These sites operate under cGMP conditions and have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the USFDA.

As a key manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical and animal health industries globally, we spoke with UQUIFA to gain key insights into:

  • Olefin Metathesis and its flexible and efficient method for making carbon-carbon bonds
  • UQUIFA’s history as a manufacturer of APIs and intermediates
  • The innovative solutions offered by UQUIFA

Click on the eBook below to learn more about how UQUIFA’s methods can help your organization bring products to market.

RELATED NEWS

Directing SMEs Through European Regulations and Their Impact on Patient-Centric Medical Devices with Dr. Ewen Northwood [Speaker Spotlight]

In this Speaker Spotlight, Dr. Ewen Northwood delves into the challenges faced by SMEs in medical device development,...

by Devyn Smith

BIC CEO Gonzalve Bich: Igniting Creativity and Growth [Speaker Spotlight]

Gonzalve Bich is the Chief Executive Officer of BIC, where he leads the development and implementation of strategic...

by Anastasiia Romanenko

Unlocking Efficiency with Stefan Fischer: The Role of Digitalization in Regulatory Processes [Speaker Spotlight]

Stefan Fischer is a seasoned professional with over 30 years of experience in the medical devices sector. His...

by Devyn Smith